Ocular Therapeutix, Inc. (OCUL)

8.26 +0.48 (+6.17%) USD  |  NASDAQ  |  Feb 23, 14:27
More

Ocular Therapeutix Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for OCUL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. Upgrade
Boston Scientific Corp. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
EyePoint Plc Upgrade
Vertex Pharmaceuticals, Inc. Upgrade